Body composition in patients with metastatic renal cell carcinoma receiving ipilimumab plus nivolumab.
Publication
, Conference
Dzimitrowicz, HE; Schwartz, F; Infield, J; Zhang, D; Ho, E; Wu, Y; Gupta, RT; Harrison, MR
Published in: JOURNAL OF CLINICAL ONCOLOGY
2022
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2022
Volume
40
Issue
16
Start / End Page
E16517 / E16517
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Dzimitrowicz, H. E., Schwartz, F., Infield, J., Zhang, D., Ho, E., Wu, Y., … Harrison, M. R. (2022). Body composition in patients with metastatic renal cell carcinoma receiving ipilimumab plus nivolumab. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40, pp. E16517–E16517).
Dzimitrowicz, Hannah Elizabeth, Fides Schwartz, Jordan Infield, Dylan Zhang, Ethan Ho, Yuan Wu, Rajan T. Gupta, and Michael Roger Harrison. “Body composition in patients with metastatic renal cell carcinoma receiving ipilimumab plus nivolumab.” In JOURNAL OF CLINICAL ONCOLOGY, 40:E16517–E16517, 2022.
Dzimitrowicz HE, Schwartz F, Infield J, Zhang D, Ho E, Wu Y, et al. Body composition in patients with metastatic renal cell carcinoma receiving ipilimumab plus nivolumab. In: JOURNAL OF CLINICAL ONCOLOGY. 2022. p. E16517–E16517.
Dzimitrowicz, Hannah Elizabeth, et al. “Body composition in patients with metastatic renal cell carcinoma receiving ipilimumab plus nivolumab.” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022, pp. E16517–E16517.
Dzimitrowicz HE, Schwartz F, Infield J, Zhang D, Ho E, Wu Y, Gupta RT, Harrison MR. Body composition in patients with metastatic renal cell carcinoma receiving ipilimumab plus nivolumab. JOURNAL OF CLINICAL ONCOLOGY. 2022. p. E16517–E16517.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2022
Volume
40
Issue
16
Start / End Page
E16517 / E16517
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences